<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363619">
  <stage>Registered</stage>
  <submitdate>4/02/2013</submitdate>
  <approvaldate>8/02/2013</approvaldate>
  <actrnumber>ACTRN12613000151730</actrnumber>
  <trial_identification>
    <studytitle>A comparison of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent erosion syndrome.</studytitle>
    <scientifictitle>A comparative clinical trial of alcohol delamination versus phototherapeutic keratectomy for the treatment of recurrent corneal erosions.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>recurrent corneal erosion syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>alcohol delamination (removal of corneal epithelium with 50um of 25% ethyl alcohol for 40 seconds)</interventions>
    <comparator>phototherapeutic keratectomy (excimer laser with 9mm treatment zone and depth of 9um). The treatment time including preparation time and epithelial debridement is less than 10 minutes.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>pain score using a numerical rating scale</outcome>
      <timepoint>24 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>recurrence of erosions by subjective report</outcome>
      <timepoint>24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>complications by slit lamp examination (eg. haze, infection, scarring) and measurement of visual acuity</outcome>
      <timepoint>24 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Individuals with symptomatic recurrent corneal erosion syndrome not responding to conservative treatment including regular topical lubrication and a bandage contact lens</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>99</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Individuals with a history of previous ocular surgery including any interventional treatment for their recurrent erosion syndrome other than manual epithelial debridement, prior herpetic eye disease, history of other corneal or external eye disease, corneal hypoaesthesia,or a history of diabetes mellitus </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Enrolment via the corneal clinic at the Hospital. Patients will only be randomised following recruitment and completion of the consent. Allocation involved contacting a trial coordinator who held a computer generated randomisation plan.</concealment>
    <sequence>Computer generated randomized  sequence</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>False</masking3>
    <masking4>False</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>31/01/2007</anticipatedstartdate>
    <actualstartdate>6/02/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>42</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>The Royal Victorian Eye and Ear Hospital - East Melbourne</hospital>
    <postcode>3002 - East Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Victorian Eye and Ear Hospital</primarysponsorname>
    <primarysponsoraddress>32 Gisborne St, East Melbourne, VIC 3002</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Centre for Eye Research Australia, University of Melbourne</sponsorname>
      <sponsoraddress>32 Gisborne St, East Melbourne, VIC 3002</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To compare two different treatment methods of reducing pain and recurrent episodes in individuals with recurrent corneal erosion syndrome, a syndrome characterised by pain, watering and light sensitivity due to episisodic loosening of the surface cells of the eye. The two methods are laser treatment and alcohol treatment to the surface of the eye. It is hypothesised that the two methods are comparable in their effect.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Royal Victorian Eye and Ear Hospital Human Research and Ethics Committee</ethicname>
      <ethicaddress>32 Gisborne St, East Melbourne, VIC 3002</ethicaddress>
      <ethicapprovaldate>18/12/2006</ethicapprovaldate>
      <hrec>06/719H</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Rasik Vajpayee</name>
      <address>Royal Victorian Eye and Ear Hospital, 32 Gisborne St, East Melbourne, VIC 3002</address>
      <phone>+61399298666</phone>
      <fax />
      <email>rasikv@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Marios Constantinou</name>
      <address>Centre for Eye Research Australia
32 Gisborne St, East Melbourne, VIC 3002</address>
      <phone>+61 3 9929 8360</phone>
      <fax />
      <email>mariosc@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Marios Constantinou</name>
      <address>Centre for Eye Research Australia
32 Gisborne St, East Melbourne, VIC 3002</address>
      <phone>+61 3 9929 8360</phone>
      <fax />
      <email>mariosc@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Elsie Chan</name>
      <address>Royal Victorian Eye and Ear Hospital
32 Gisborne St, East Melbourne, VIC 3002</address>
      <phone>+61399298666</phone>
      <fax />
      <email>elsie.chan@eyeandear.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>